PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION
Live / Registered — Registered and renewed (as of 14 Jan 2026)
What this means for you
Registered since 13 Oct 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2025).
Record
- Serial number
- 85498760
- Registration number
- 4832089
- Mark type
- Stylized text
- Filed
- 19 Dec 2011
- Published for opposition
- 24 Dec 2013
- Registered
- 13 Oct 2015
- Next maintenance due
- 13 Oct 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 14 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Jan 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Jan 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Sept 2025 — TEAS SECTION 8 & 9 RECEIVED
- 13 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 04 Aug 2022 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15